Inotiv, inc. enhances histopathology offering with announcement of agreement to purchase histotox labs, inc.

West lafayette, ind., april 13, 2021 (globe newswire) -- inotiv, inc. (nasdaq:notv) (the “company”, “we”, “our” or “inotiv”), a leading provider of nonclinical and analytical contract research services, today announced that the company has entered into an agreement to purchase substantially all of the assets of histotox labs, inc. (“histotox labs”), a full-service histopathology contract research organization (“cro”) offering medically relevant non-clinical and clinical services to the pharmaceutical, biotech, and academic communities.
NOTV Ratings Summary
NOTV Quant Ranking